| Plasma Cell Leukemia studied in …STUDIED_INderived53 of 53show fewer |
|---|
| → studied in | NCT07605416Phase 2 · recruiting Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07652905Phase 2 · recruiting CM336 Plus Isa-VR in Newly Diagnosed Primary Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03389347NA · completed High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05283993recruiting A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06517017Phase 2 · recruiting Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092451Phase 1/Phase 2 · recruiting Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855121recruiting The Norwegian Immunotherapy in Multiple Myeloma Study · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07649525Phase 3 · recruiting Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805605Phase 2 · recruiting Allo HSCT Using RIC and PTCy for Hematological Diseases · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05870917Phase 2 · active not recruiting A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03314974Phase 2 · recruiting Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05405387Phase 2 · recruiting Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01962636NA · terminated Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02334865Phase 1 · active not recruiting SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy · condition mapped PROBABILISTIC · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07509086Phase 2 · recruiting IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03123029available Expanded Access to Venetoclax · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07185490early Phase 1 · not yet recruiting IASO104 for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05556928recruiting Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06237803recruiting European Myeloma Network (EMN) Sample Project · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03717844recruiting Registry for Adults With Plasma Cell Disorders (PCD's) · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02315157Phase 1 · withdrawn Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05823571Phase 1 · active not recruiting Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07109323Phase 1/Phase 2 · recruiting Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05979363Phase 2 · recruiting A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06988059early Phase 1 · recruiting A Study of CT0596 in Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07085559early Phase 1 · recruiting Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02722668Phase 2 · completed UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05219721Phase 1 · recruiting A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05759793Phase 1 · recruiting A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01729091Phase 2 · completed Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06830733Phase 2 · not yet recruiting Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01163357Phase 1 · completed Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506959Phase 2 · completed Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06655519Phase 1 · not yet recruiting An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02547662Phase 2 · completed Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02661035Phase 2 · completed Allo HSCT Using RIC for Hematological Diseases · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06045091early Phase 1 · recruiting To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05893693NA · unknown Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia · condition mapped CURATED_BROADER · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05822037NA · unknown CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02556931Phase 2 · completed Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05054478Phase 2 · not yet recruiting Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02504359Phase 1 · completed Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00821249Phase 1/Phase 2 · completed A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01372540Phase 1 · completed Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04008888NA · unknown a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01008462Phase 2 · completed Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03591744Phase 1 · withdrawn Daratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Treating Participants With Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03100877Phase 1/Phase 2 · withdrawn Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma · condition mapped CURATED_BROADER · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00307086Phase 2 · completed Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01658904Phase 1/Phase 2 · terminated Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00615589Phase 2 · terminated Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01435720Phase 1/Phase 2 · unknown Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01328236Phase 2 · unknown Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia · condition mapped ONTOLOGY_EXACT · 53 trials mapped (28 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |